DRAXIMAGE DTPA Drug Patent Profile
✉ Email this page to a colleague
When do Draximage Dtpa patents expire, and when can generic versions of Draximage Dtpa launch?
Draximage Dtpa is a drug marketed by Jubilant and is included in one NDA.
The generic ingredient in DRAXIMAGE DTPA is technetium tc-99m pentetate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.
Summary for DRAXIMAGE DTPA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in DRAXIMAGE DTPA? | DRAXIMAGE DTPA excipients list |
| DailyMed Link: | DRAXIMAGE DTPA at DailyMed |
Pharmacology for DRAXIMAGE DTPA
| Drug Class | Lead Chelator |
| Mechanism of Action | Lead Chelating Activity |
US Patents and Regulatory Information for DRAXIMAGE DTPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant | DRAXIMAGE DTPA | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 018511-001 | Dec 29, 1989 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
